Scientists in the US claim to have discovered a new antibiotic, which can not adapt pathogenic microbes. Researchers themselves formulate its conclusion with the utmost care, but the media are already talking about the opening, which can be a breakthrough for medicine.
The study involved researchers from Northeastern University in Boston, USA, the company Novobiotics Pharmaceuticals, as well as research centers in Germany and the UK. The work was done with a drug called teixobactin, previously patented Novobiotics Pharmaceuticals.
The substance was given to mice infected with staphylococcus and tuberculosis. Media is added to this list and streptococcal infections. The drug treated animals without hurting them. Thus, mice cured of the infection of the skin, and lung tissues of the hip. Simultaneously, the causative agent is not able to create drug resistance mutations.
“The properties of this compound show the way to the creation of antibiotics is likely that avoid generating sustainability” – scientists say. This is not an idle question. In recent years, antibiotic resistance spreads faster than the introduction of new compounds in clinical practice.
trials in humans have not yet been. Their preparation and conduct, according to journalists, may take several years.
No comments:
Post a Comment